Corporate News     16-Feb-23
Shilpa Medicare's Bengaluru facility gets registered with Ministry of Health, UAE
Paves way for registration of products in UAE for commercialization
Shilpa Medicare's Bengaluru facility for manufacture and testing of Orodispersible films and Transdermal systems has been successfully registered with Ministry of Health, United Arab Emirates. This registration enables company to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization.

The facility is involved in manufacturing and testing of specialized dosage forms eg. Orodispersible Films and Transdermal systems. The facility is backed up with strong Research and Development of Orodispersible films and transdermal technologies. The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements. The facility has already been issued GMP by UK MHRA.

The facility also manufactures dietary supplements in orodispersible films and was registered with US FDA Food Facility registry. The facility is actively exporting dietary supplements to US Market.

Previous News
  Shilpa Medicare Ltd leads losers in 'A' group
 ( Hot Pursuit - 29-Dec-23   15:00 )
  Shilpa Medicare AGM scheduled
 ( Corporate News - 05-Sep-23   15:26 )
  Shilpa Medicare spurts as Bengaluru facility registers with Ministry of Health, UAE
 ( Hot Pursuit - 16-Feb-23   15:17 )
  Shilpa Medicare announces board meeting date
 ( Corporate News - 16-May-24   16:56 )
  Shilpa Medicare's Bengaluru facility gets registered with Ministry of Health, UAE
 ( Corporate News - 16-Feb-23   14:39 )
  Shilpa Medicare receives Europe approval for Varenicline Tablets
 ( Corporate News - 26-Feb-24   11:06 )
  Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics
 ( Corporate News - 04-Sep-24   15:14 )
  Shilpa Medicare consolidated net profit rises 341.54% in the December 2019 quarter
 ( Results - Announcements 11-Feb-20   08:42 )
  Shilpa Medicare receives USFDA warning letter for its Jadcherla facility, Telangana
 ( Corporate News - 12-Oct-20   12:55 )
  Shilpa Medicare receives USFDA tentative approval for Apremilast Tablets
 ( Corporate News - 05-Mar-21   11:00 )
  Board of Shilpa Medicare approves appointment of CFO
 ( Corporate News - 31-May-21   21:10 )
Other Stories
  ITD Cementation India wins order of Rs 1,937 cr
  03-Oct-24   10:35
  NIIT Learning Systems allots 1,666 equity shares under ESOP
  03-Oct-24   10:30
  Ashoka Metcast to discuss results
  03-Oct-24   10:29
  Emerald Finance to declare Quarterly Result
  03-Oct-24   10:29
  Rhetan TMT schedules board meeting
  03-Oct-24   10:29
  Shrenik to table results
  03-Oct-24   10:29
  Universal Arts to declare Quarterly Result
  03-Oct-24   10:28
  Three M Paper Boards to conduct board meeting
  03-Oct-24   10:28
  Arkade Developers to declare Quarterly Result
  03-Oct-24   10:28
  Worth Investment & Trading Company announces board meeting date
  03-Oct-24   10:28
Back Top